26 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
and the Public Company Accounting Oversight Board.
4.5 Capitalization. The authorized capital stock of the Company consists of 700,000,000 shares … conditions of approval and policies imposed by any institutional review board, ethics review board or committee responsible for the oversight
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
an optimal board leadership structure to ensure the independent oversight of management as the company continues to grow. The lead independent director … of oversight, independence and responsibility is applied to all board decisions.
The duties of our lead independent director include the following
8-K
EX-10.1
pq1835c 5ebh
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-1.1
zhmdv351
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
clmjh0fgy08 0pkrbx5
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
DEF 14A
pr6f0j fw504p7
30 Apr 19
Definitive proxy
4:04pm
10-K
g1ltrv2
22 Mar 19
Annual report
4:45pm
424B4
hq1rgt63pxb afzc5
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
hmt56u
23 Jan 19
IPO registration (amended)
4:39pm